Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› North York
Clinical trial register · Canada

Clinical Trials in North York, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Canada and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6567 matching records held by the registry are in this view. Synced 13 Nov 2026, 03:20 UTC
6567
Studies in scope
all four open statuses
3491
Recruiting now
open to new participants
883
Lead sponsors
across recruiting studies
Top sites
Toronto 2824 Montreal 1918 Vancouver 1190 Calgary 1067 Edmonton 1024
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca13 Novartis Pharmaceuticals4 University Health Network, Toronto4 Merck Sharp & Dohme LLC4 Amgen3 Subodh Verma2 Sunnybrook Health Sciences Centre2 Takeda2 Eli Lilly and Company2 Hoffmann-La Roche2 The Hospital for Sick Children1 Karen Rowa1 University of Alberta1 Colorado Prevention Center1 FUSMobile Inc.1 McMaster University1 Abivax S.A.1 The University of Queensland1 Spiderwort Biotechnologies Inc.1 Galderma R&D1 Triveni Bio1 AgNovos Healthcare, LLC1 Jaeb Center for Health Research1 North York General Hospital1 TIDHI Innovation Inc.1 Show all 40
Site location
Toronto2824 Montreal1918 Vancouver1190 Calgary1067 Edmonton1024 Ottawa884 London880 Hamilton813 Québec685 Halifax534 Winnipeg455 Sherbrooke269 Kingston255 Kelowna177 Brampton144 Surrey141 Victoria129 St. John's127 Barrie126 Saskatoon125 Chicoutimi100 Moncton93 Mississauga89 Greater Sudbury84 Regina82 Show all 249
All 249 locations
Target enrolment
to

Trials with a site in North York

68 of 6567 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Canada
Start
Not yet open
Novo Nordisk A/S
Phase 3
8,500
Edmonton, Red Deer, Vancouver, Moncton, Truro, London, Mississauga, North York
2026-10-26
Recruiting
AstraZeneca
Phase 3
1,330
Calgary, Edmonton, Abbotsford British Columbia, Brampton, Kitchener, North York, Ottawa, Toronto
2026-09-15
By invitation
Family Accommodation Reduction in Adult Obsessive Compulsive Disorder
NCT07912177Obsessive - Compulsive Disorder, Family Accommodation, OCD, CBT
Karen Rowa
Not applicable
480
Hamilton, North York
2026-09-10
Recruiting
AstraZeneca
Phase 3
200
Cambridge, Guelph, Mississauga, North York, Stoney Creek, Toronto
2026-09-10
Recruiting
Neurolysis for the Treatment of Medial Chronic Knee Pain Due to Osteoarthritis
NCT07178951Osteoarthritis (OA) of the Knee, Knee Pain Arthritis, Chronic Knee Pain
FUSMobile Inc.
Not applicable
10
North York
2026-09-09
Recruiting
AstraZeneca
Phase 3
1,500
Calgary, Vancouver, Moncton, Truro, Hamilton, Markham, North York, Sarnia
2026-08-20
Recruiting
A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis
NCT07521007Atherosclerosis, Coronary Artery Disease
Beijing Inno Medicine Co., Ltd.
Phase 2
456
Winnipeg, London, North York, Toronto, Vaughan
2026-07-31
Recruiting
AstraZeneca
Phase 3
600
Surrey, Vancouver, Brampton, North York, Sarnia, Scarborough Village, Toronto, Saint-Charles-Borromée
2026-07-08
Not yet open
Baxdrostat and Ventricular Remodeling
NCT07655362Cardiac Remodeling
DrugBaxdrostat
Subodh Verma
Phase 3
286
North York, Toronto
2026-06-30
Recruiting
Merck Sharp & Dohme LLC
Phase 2
750
North York, Chicoutimi, Québec, Trois-Rivières
2026-06-30
Recruiting
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
NCT07652658Idiopathic Pulmonary Fibrosis (IPF)
AstraZeneca
Phase 2
359
Sherwood Park, Vancouver, Ajax, Burlington, Kingston, North York, Saint-Charles-Borromée, Sherbrooke
2026-06-11
Recruiting
ParagonClinicals Inc.
Phase 2
82
Brampton, London, Mississauga, North York
2026-05-20
Not yet open
Using Music During Wound Care Among Seniors With Pressure Injuries
NCT07456618Pressure Injuries, Pressure Injury, Pressure Ulcer (PU)
McMaster University
Not applicable
50
Burlington, Hagersville, Hamilton, Mississauga, North York, Stoney Creek, Strathroy, Toronto
2026-04-01
Recruiting
Novartis Pharmaceuticals
Phase 3
770
North York, Montreal
2026-03-24
Not yet open
York University
Not applicable
60
North York
2026-03-20
Recruiting
Exciva GmbH
Phase 2/3
300
North York, Peterborough, Whitby
2026-02-02
Not yet open
University of British Columbia
Not applicable
914
Edmonton, Barrie, London, North York, Vancouver
2026-01-01
Not yet open
Finerenone and Cardiac Remodeling
NCT07270367Heart Failure
DrugsKerendia·Finerenone
Subodh Verma
Phase 3
156
Cambridge, North York, Toronto
2025-12
Active, closed
Merck Sharp & Dohme LLC
Phase 3
996
Moncton, London, North York, Thunder Bay, Mirabel, Québec
2025-11-11
Active, closed
Hoffmann-La Roche
Phase 3
1,101
Richmond, North YORK, Toronto, Montreal, Québec
2025-09-17
Recruiting
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
NCT07157774Elevated Lp(a), Atherosclerotic Cardiovascular Disease (ASCVD)
Eli Lilly and Company
Phase 3
10,450
Chicoutimi, Etobicoke, Hamilton, Joliette, Longueuil, Moncton, Montreal, North York
2025-09-02
Active, closed
Triveni Bio
Phase 2
95
Ajax, Newmarket, Niagara Falls, North York
2025-08-26
Active, closed
Novartis Pharmaceuticals
Phase 2
96
London, North York, Ottawa, Toronto
2025-08-07
Active, closed
Amgen
Phase 3
12,800
Edmonton, Vancouver, Victoria, Moncton, Brampton, Cambridge, North York, Scarborough Village
2025-07-25
Recruiting
TIDHI Mental Health in IBD Patients Study
NCT07013578Crohn Disease (CD), Ulcerative Colitis (UC), Inflammatory Bowel Disease (IBD)
TIDHI Innovation Inc.
Not applicable
100
North York
2025-07-22
Recruiting
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
NCT07037459Heart Failure With Preserved Ejection Fraction, Heart Failure With Mildly Reduced Ejection Fraction, Obesity
DrugMaridebart cafraglutide
Amgen
Phase 3
5,056
Edmonton, Winnipeg, Brampton, Cambridge, Newmarket, North York, Peterborough, Sarnia
2025-06-25
Recruiting
Sunnybrook Health Sciences Centre
Not applicable
60
North York
2025-06-19
Active, closed
AstraZeneca
Phase 3
3,103
Surrey, Vancouver, Cambridge, Courtice, Guelph, Hamilton, Mississauga, North York
2025-05-28
Active, closed
Zura Bio Inc
Phase 2
247
Newmarket, North York, Richmond Hill, Québec, Saskatoon
2025-05-16
Recruiting
Hoffmann-La Roche
Phase 3
425
Barrie, Brampton, London, North YORK, Montreal
2025-05-12
Recruiting
University Health Network, Toronto
Observational
3,000
Surrey, Moncton, North York, Saint Catharines, Toronto, Montreal
2025-04-14
Active, closed
Histological Analysis of CelluJuve® Injections in the Brachium
NCT06930209Healthy Male and Female Subjects
Spiderwort Biotechnologies Inc.
Not applicable
10
North York
2025-03-28
Active, closed
Amgen
Phase 3
3,853
Surrey, Hamilton, North York, Oshawa, Scarborough Village, Thunder Bay, Toronto, Chicoutimi
2025-03-12
Active, closed
4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration
NCT06864988Macular Neovascularization Secondary to Age-Related Macular Degeneration
DrugsEYLEA (aflibercept)·4D-150 IVT
4D Molecular Therapeutics
Phase 3
480
Calgary, New Westminster, North York, Ottawa
2025-03-03
Active, closed
Chrysalis Dental Center
Observational
2,700
North York
2025-01-31
Active, closed
Canadian Medical and Surgical Knowledge Translation Research Group
Observational
120
Markham, North York, Scarborough Village, Woodbridge
2025-01-30
Recruiting
Sunnybrook Health Sciences Centre
Phase 1
100
North York, Toronto
2025-01-06
Recruiting
University of Alberta
Not applicable
100
Calgary, Edmonton, St. Albert, Hamilton, North York, Toronto, Regina
2024-11-14
Recruiting
North York General Hospital
Not applicable
68
North York
2024-10-22
Active, closed
Merck Sharp & Dohme LLC
Phase 3
3,000
North Vancouver, Cambridge, North York, Chicoutimi, Montreal, Trois-Rivières
2024-08-05
Recruiting
Colorado Prevention Center
Phase 3
1,500
Edmonton, Surrey, Greater Sudbury, London, North York, Toronto, Montreal, Sherbrooke
2024-07-09
Active, closed
Takeda
Phase 4
60
Barrie, London, Mississauga, North Bay, North York, Oakville, Oshawa, Vaughan
2024-06-12
Active, closed
Eli Lilly and Company
Phase 3
10,000
Calgary, Chicoutimi, Courtice, Edmonton, London, Moncton, North York, Oshawa
2024-04-30
Active, closed
Takeda
Phase 4
50
Edmonton, London, North Bay, North York, Oakville, Vaughan, Montreal
2024-04-18
Recruiting
Novartis Pharmaceuticals
Phase 2
502
Cambridge, North York, Ottawa, Montreal, Québec
2024-03-07
Active, closed
AstraZeneca
Phase 3
594
Barrie, London, North York, Ottawa, Toronto, Montreal
2024-03-04
Active, closed
Incyte Corporation
Phase 3
467
Calgary, Surrey, Burlington, London, North YORK, Ottawa, Peterborough, Waterloo
2023-11-29
Recruiting
University Health Network, Toronto
Observational
500
North York, Toronto
2023-11-11
Active, closed
Home OCT-Guided Treatment Versus Treat and Extend for the Management of Neovascular AMD
NCT05904028Neovascular Age-related Macular Degeneration
Jaeb Center for Health Research
Phase 3
603
North YORK, Toronto
2023-11-09
Recruiting
Albumin To Enhance Recovery After Acute Kidney Injury
NCT04705896Acute Kidney Injury, Renal Replacement Therapy, Hypotension, Critical Illness
Ottawa Hospital Research Institute
Phase 4
856
Calgary, Winnipeg, Halifax, Hamilton, Kingston, North York, Ottawa, Scarborough Village
2023-11-02
Active, closed
Merck Sharp & Dohme LLC
Phase 3
14,550
Kelowna, Cambridge, North York, Oakville, Toronto, Chicoutimi, Montreal, Québec
2023-10-09
Active, closed
DBV Technologies
Phase 3
600
Vancouver, Winnipeg, Burlington, North York, Ottawa, Toronto, Montreal, Québec
2023-02-21
Active, closed
ABTECT - Maintenance
NCT05535946Ulcerative Colitis
DrugObefazimod
Abivax S.A.
Phase 3
1,116
Edmonton, Vancouver, London, North York
2023-01-16
Active, closed
AriBio Co., Ltd.
Phase 3
1,535
Halifax, Kelowna, London, North York, Peterborough, Toronto, Victoria, West Vancouver
2022-12-23
Active, closed
Novartis Pharmaceuticals
Phase 3
610
North York, Ottawa, Montreal
2022-07-08
Active, closed
The Hospital for Sick Children
Not applicable
615
Edmonton, Brampton, Etobicoke, Markham, Mississauga, Newmarket, North York, Oshawa
2021-11-11
Recruiting
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
NCT05065216Acute Stroke, Ischemic Stroke, Stroke
DiaMedica Therapeutics Inc
Phase 2/3
728
Edmonton, Vancouver, Hamilton, North York
2021-11-07
Active, closed
AstraZeneca
Phase 3
732
North York, Toronto, Montreal, Québec
2021-10-18
Active, closed
Prevention of Persistent Pain With LidocAine iNfusions in Breast Cancer Surgery (PLAN)
NCT04874038Post-mastectomy Pain Syndrome, Breast Cancer, Pain, Postoperative, Pain, Chronic
DrugLidocaine
University Health Network, Toronto
Phase 3
1,604
Calgary, Edmonton, St. John's, Halifax, Hamilton, North York, Ottawa, Thunder Bay
2021-09-22
Active, closed
AstraZeneca
Phase 3
1,157
Calgary, Halifax, Barrie, Kitchener, Newmarket, North York, Toronto, Montreal
2021-04-26
Recruiting
RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures
NCT04796350Fragility Fracture, Hip Fractures, Osteoporosis
AgNovos Healthcare, LLC
Not applicable
2,400
St. John's, Halifax, North York
2021-04-24
Active, closed
Galderma R&D
Phase 3
500
Calgary, London, North York, Saskatoon, Markham, Toronto
2021-01-11
Active, closed
AstraZeneca
Phase 3
957
Edmonton, North York, Oshawa, Toronto, Montreal
2020-11-17
Active, closed
AstraZeneca
Phase 3
818
Winnipeg, Kingston, North York, Toronto
2020-04-16
Recruiting
The University of Queensland
Not applicable
3,600
Calgary, Edmonton, Vancouver, Winnipeg, Halifax, Kingston, London, North York
2019-12-10
Active, closed
AstraZeneca
Phase 3
923
Victoria, Kitchener, North York, Toronto
2019-06-25
Active, closed
AstraZeneca
Phase 2
367
Calgary, Edmonton, Newmarket, North York, Toronto
2019-01-09
Active, closed
University Health Network, Toronto
Not applicable
90
North York, Toronto
2018-11-16
Rows per page Showing 1–68 of 68
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Canadian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 14 November 2026. https://priyalifescience.com/clinical-trials-canada/city/north-york

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Canada and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,567 studies in total at the last sync on 13 Nov 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 68 of those studies with a site in North York.

How many clinical trials are recruiting in North York?

27 of the 68 studies on this page are recruiting new participants as of the 13 Nov 2026, 03:20 UTC sync. A further 6 have not yet opened recruitment, 34 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (North York), 68 studies
PhaseStudiesRecruitingShare
Phase 335951.5%
Not applicable14720.6%
Phase 29513.2%
Observational425.9%
Phase 4314.4%
Phase 2/3222.9%
Phase 1111.5%

Most active sponsors

Lead sponsors with the most studies (North York)
Lead sponsorStudiesRecruiting
AstraZeneca135
Merck Sharp & Dohme LLC41
Novartis Pharmaceuticals42
University Health Network, Toronto42
Amgen31
Eli Lilly and Company21
Hoffmann-La Roche21
Subodh Verma20
Sunnybrook Health Sciences Centre22
Takeda20
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.